Innovation Pharmaceuticals Inc (IPIX)

[John B]

Thanks Jok! Another well written piece by Ellaruth. I look forward to the day when we are not overlooked by the Media, and the Market/analysts/institutions. At least we have garnered the interest of Harvard's Dana Farber, Beth Israel, MD Anderson and the University of Bologna. How these other entities ignore that is beyond me.
In the comments: "My next blog will be "Why I believe Kevetrin will attract FDA consideration for approval during FDA 3" There are three reasons."
Looking forward to reading that one also. Great job Ellaruth!